Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.

@article{Natale2015ReviewingCA,
  title={Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.},
  author={James J Natale},
  journal={Hospital practice},
  year={2015},
  volume={43 4},
  pages={226-34}
}
This review provides background information on chemotherapy-induced nausea and vomiting (CINV) classification and pathophysiology and reviews various antiemetic agents for CINV prophylaxis, including corticosteroids, serotonin receptor antagonists (5-HT3 RAs), tachykinin NK1 receptor antagonists (NK1 RAs), and olanzapine. Other less commonly used agents are briefly discussed. Practical considerations are reviewed as well, including emetogenicity of chemotherapeutic regimens, patient-specific… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 21 times over the past 90 days. VIEW TWEETS